Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer

Clinical trial NCT00625651 · COMPLETED

Trial details

NCT number: NCT00625651
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer Colon Cancer Colorectal Cancer Rectal Cancer

Start date: 2007-10-01
Primary completion: 2010-08-01
Enrollment: 202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.